Skip to main content Skip to search

Oncología Genitourinaria y Celular y Molecular

Publicaciones

2017

Escudier B, Sharma P, McDermott DF, George S, Hammers HJ, Srinivas S, Tykodi SS, Sosman JA, Procopio G, Plimack ER, Castellano D, Gurney H, Donskov F, Peltola K, Wagstaff J, Gauler TC, Ueda T, Zhao H, Waxman IM, Motzer RJ, CheckMate 025 investigators (2017).

CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors; and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell; Carcinoma

EUROPEAN UROLOGY. Article. 72(6):962-971.
[doi:10.1016/j.eururo.2017.02.010]
de Velasco G, McKay RR, Lin X, Moreira RB, Simantov R, Choueiri TK (2017).

Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell; Carcinoma Patients Treated in Clinical Trials

CLINICAL GENITOURINARY CANCER. Article. 15(6):652.
[doi:10.1016/j.clgc.2017.03.004]
Guerrero-Ramos F, Lara-Isla A, Justo-Quintas J, Duarte-Ojeda JM, de la Rosa-Kehrmann F, Villacampa-Aubá F (2017).

Adjuvant intravesical treatment for nonmuscle invasive bladder cancer:; The importance of the strain and maintenance

ACTAS UROLOGICAS ESPANOLAS. Article. 41(9):590-595.
[doi:10.1016/j.acuro.2017.03.003]
van der Zanden LF, Vermeulen SH, Oskarsdottir A, Maurits JS, Diekstra MH, Ambert V, Cambon-Thomsen A, Castellano D, Fritsch A, Garcia Donas J, Guarch Troyas R, Guchelaar HJ, Hartmann A, Hulsbergen-van de Kaa C, Jaehde U, Junker K, Martinez-Cardus A, Masson G, Oosterwijk-Wakka J, Radu MT, Rafnar T, Rodriguez-Antona C, Roessler M, Ruijtenbeek R, Stefansson K, Warren A, Wessels L, Eisen T, Kiemeney LA, Oosterwijk E (2017).

Description of the EuroTARGET cohort: A European collaborative project; on TArgeted therapy in renal cell cancer-GEnetic- and tumor-related; biomarkers for response and toxicity

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. Article. 35(8).
[doi:10.1016/j.urolonc.2017.03.009]
Meyer CP, Sun M, Karam JA, Leow JJ, de Velasco G, Pal SK, Chang SL, Trinh QD, Choueiri TK (2017).

Complications After Metastasectomy for Renal Cell Carcinoma-A; Population-based Assessment

EUROPEAN UROLOGY. Article. 72(2):171-174.
[doi:10.1016/j.eururo.2017.03.005]
Apellániz-Ruiz M, Diekstra MH, Roldán JM, Boven E, Castellano D, Gelderblom H, Mathijssen RHJ, Swen JJ, Böhringer S, García-Donás J, Rini BI, Guchelaar HJ, Rodríguez-Antona C (2017).

Evaluation of KDR rs34231037 as a predictor of sunitinib efficacy in; patients with metastatic renal cell carcinoma

PHARMACOGENETICS AND GENOMICS. Article. 27(6):227-231.
[doi:10.1097/FPC.0000000000000280]
De Velasco G, Xie W, Donskov F, Albiges L, Beuselinck B, Srinivas S, Agarwal N, Lee JL, Brugarolas J, Wood LA, Rha SY, Kollmannsberger C, North S, Kanesvaran R, Rini BI, Broom R, Yamamoto H, Kaymakcalan MD, Heng DY, Choueiri TK (2017).

Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity; Affects Outcomes of Second-line Therapies in Metastatic Renal Cell; Carcinoma

CLINICAL GENITOURINARY CANCER. Article. 15(3):403-410.
[doi:10.1016/j.clgc.2017.01.005]
García-Donas J, Font A, Pérez-Valderrama B, Virizuela JA, Climent MÁ, Hernando-Polo S, Arranz JÁ, Del Mar Llorente M, Lainez N, Villa-Guzmán JC, Mellado B, Del Alba AG, Castellano D, Gallardo E, Anido U, Del Muro XG, Domènech M, Puente J, Morales-Barrera R, Pérez-Gracia JL, Bellmunt J (2017).

Maintenance therapy with vinflunine plus best supportive care versus; best supportive care alone in patients with advanced urothelial; carcinoma with a response after first-line chemotherapy (MAJA; SOGUG; 2011/02): a multicentre, randomised, controlled, open-label, phase 2; trial

LANCET ONCOLOGY. Article. 18(5):672-681.
[doi:10.1016/S1470-2045(17)30242-5]
Geynisman DM, De Velasco G, Sewell KL, Jacobs I (2017).

Biosimilar biologic drugs: a new frontier in medical care

POSTGRADUATE MEDICINE. Review. 129(4):460-470.
[doi:10.1080/00325481.2017.1311196]
Massard C, Chi KN, Castellano D, de Bono J, Gravis G, Dirix L, Machiels JP, Mita A, Gonzalez BM, Turri S, Maier J, Csonka D, Chakravartty A, Fizazi K (2017).

Phase Ib dose-finding study of abiraterone acetate plus buparlisib; (BKM120) or dactolisib (BEZ235) in patients with castration-resistant; prostate cancer

EUROPEAN JOURNAL OF CANCER. Article. 76:36-44.
[doi:10.1016/j.ejca.2017.01.024]
de Lena PG, Paz-Gallardo A, Paramio JM, García-Escudero R (2017).

Clusterization in head and neck squamous carcinomas based on lncRNA; expression: molecular and clinical correlates

Clinical epigenetics. Article. 9:36-36.
[doi:10.1186/s13148-017-0334-6]
Capdevila J, Casanovas O, Salazar R, Castellano D, Segura A, Fuster P, Aller J, García-Carbonero R, Jimenez-Fonseca P, Grande E, Castaño JP (2017).

Translational research in neuroendocrine tumors: pitfalls and; opportunities

ONCOGENE. Review. 36(14):1899-1907.
[doi:10.1038/onc.2016.316]
Gonzalez-Billalabeitia E, Castellano D, Sobrevilla N, Guma J, Hervas D, Luengo MI, Aparicio J, Sanchez-Muñoz A, Mellado B, Saenz A, Valverde C, Fernandez A, Margeli M, Duran I, Fernandez S, Sastre J, Ros S, Maroto P, Manneh R, Cerezuela P, Carmona-Bayonas A, Spanish Germ Cell Cancer Group/Grupo Germinal (SGCCG) (2017).

Prognostic Significance of Venous Thromboembolic Events in Disseminated; Germ Cell Cancer Patients

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. Article. 109(4).
[doi:10.1093/jnci/djw265]
Loizaga-Iriarte A, Rodriguez-Antolin A, Miñana B, Lacasa-Viscasillas I, Senarriaga-Ruiz de la Illa N, Cozar-Olmo JM, Unda-Urzaiz M (2017).

Castrate resistant prostate cancer. Consensus recommendations of the; Spanish Association of Urology

ACTAS UROLOGICAS ESPANOLAS. Editorial Material. 41(3):141-145.
[doi:10.1016/j.acuro.2016.09.001]
De Velasco G, Je Y, Bossé D, Awad MM, Ott PA, Moreira RB, Schutz F, Bellmunt J, Sonpavde GP, Hodi FS, Choueiri TK (2017).

Comprehensive Meta-analysis of Key Immune-Related Adverse Events from; CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients

Cancer Immunology Research. Article. 5(4):312-318.
[doi:10.1158/2326-6066.CIR-16-0237]
Riveiro-Falkenbach E, Ruano Y, García-Martín RM, Lora D, Cifdaloz M, Acquadro F, Ballestin C, Ortiz-Romero PL, Soengas MS, Rodríguez-Peralto JL (2017).

DEK oncogene is overexpressed during melanoma progression

PIGMENT CELL & MELANOMA RESEARCH. Article. 30(2):194-202.
[doi:10.1111/pcmr.12563]
Jiménez-Romero C, Conde M, de la Rosa F, Manrique A, Calvo J, Caso Ó, Muñoz C, Marcacuzco A, Justo I (2017).

Treatment of caval vein thrombosis associated with renal tumors

CIRUGIA ESPANOLA. Article. 95(3):152-159.
[doi:10.1016/j.ciresp.2017.01.004]
de Velasco G, Culhane AC, Fay AP, Hakimi AA, Voss MH, Tannir NM, Tamboli P, Appleman LJ, Bellmunt J, Kimryn Rathmell W, Albiges L, Hsieh JJ, Heng DY, Signoretti S, Choueiri TK (2017).

Molecular Subtypes Improve Prognostic Value of International Metastatic; Renal Cell Carcinoma Database Consortium Prognostic Model

ONCOLOGIST. Article. 22(3):286-292.
[doi:10.1634/theoncologist.2016-0078]
González-Larriba JL, Maroto P, Durán I, Lambea J, Flores L, Castellano D, The Changing Group (2017).

The role of mTOR inhibition as second-line therapy in metastatic renal; carcinoma: clinical evidence and current challenges

EXPERT REVIEW OF ANTICANCER THERAPY. Review. 17(3):217-226.
[doi:10.1080/14737140.2017.1273774]
Faivre S, Niccoli P, Castellano D, Valle JW, Hammel P, Raoul JL, Vinik A, Van Cutsem E, Bang YJ, Lee SH, Borbath I, Lombard-Bohas C, Metrakos P, Smith D, Chen JS, Ruszniewski P, Seitz JF, Patyna S, Lu DR, Ishak KJ, Raymond E (2017).

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free; survival and final overall survival from a phase III randomized study

ANNALS OF ONCOLOGY. Article. 28(2):339-343.
[doi:10.1093/annonc/mdw561]
Perez-Gracia JL, Sanmamed MF, Bosch A, Patiño-Garcia A, Schalper KA, Segura V, Bellmunt J, Tabernero J, Sweeney CJ, Choueiri TK, Martín M, Fusco JP, Rodriguez-Ruiz ME, Calvo A, Prior C, Paz-Ares L, Pio R, Gonzalez-Billalabeitia E, Gonzalez Hernandez A, Páez D, Piulats JM, Gurpide A, Andueza M, de Velasco G, Pazo R, Grande E, Nicolas P, Abad-Santos F, Garcia-Donas J, Castellano D, Pajares MJ, Suarez C, Colomer R, Montuenga LM, Melero I (2017).

Strategies to design clinical studies to identify predictive biomarkers; in cancer research

CANCER TREATMENT REVIEWS. Review. 53:79-97.
[doi:10.1016/j.ctrv.2016.12.005]
Feber A, Dhami P, Dong L, de Winter P, Tan WS, Martínez-Fernández M, Paul DS, Hynes-Allen A, Rezaee S, Gurung P, Rodney S, Mehmood A, Villacampa F, de la Rosa F, Jameson C, Cheng KK, Zeegers MP, Bryan RT, James ND, Paramio JM, Freeman A, Beck S, Kelly JD (2017).

UroMark-a urinary biomarker assay for the detection of bladder cancer

Clinical epigenetics. Article. 9:8-8.
[doi:10.1186/s13148-016-0303-5]
Liu X, Swen JJ, Boven E, Castellano D, Gelderblom H, Mathijssen RH, Rodríguez-Antona C, García-Donas J, Rini BI, Guchelaar HJ (2017).

Meta-analysis on the association of VEGFR1 genetic variants with; sunitinib outcome in metastatic renal cell carcinoma patients

Oncotarget. Article. 8(1):1204-1212.
[doi:10.18632/oncotarget.13597]
Diekstra MH, Belaustegui A, Swen JJ, Boven E, Castellano D, Gelderblom H, Mathijssen RH, García-Donas J, Rodríguez-Antona C, Rini BI, Guchelaar HJ (2017).

Sunitinib-induced hypertension in CYP3A4 rs4646437 A-allele carriers; with metastatic renal cell carcinoma

PHARMACOGENOMICS JOURNAL. Article. 17(1):42-46.
[doi:10.1038/tpj.2015.100]

2016

Dallavalle, C, Albino, D, Civenni, G, Merulla, J, Ostano, P, Mello-Grand, M, Rossi, S, Losa, M, D'Ambrosio, G, Sessa, F, Thalmann, GN, Garcia-Escudero, R, Zitella, A, Chiorino, G, Catapano, CV, Carbone, GM (2016).

MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression

JOURNAL OF CLINICAL INVESTIGATION. Article. 126(12):4585-4602.
[doi:10.1172/JCI86505]
Alameda, Josefa P., Navarro, Manuel, Ramirez, Angel, Page, Angustias, Suarez-Cabrera, Cristian, Moreno-Maldonado, Rodolfo, Paramio, Jesus M., del Carmen Farina, Maria, Del Rio, Marcela, Jesus Fernandez-Acenero, Maria, Bravo, Ana, de los Llanos Casanova, Maria (2016).

IKK alpha regulates the stratification and differentiation of the epidermis: implications for skin cancer development

Oncotarget. Article. 7(47):76779-76792.
[doi:10.18632/oncotarget.12527]
Gargini R, Escoll M, García E, García-Escudero R, Wandosell F, Antón IM (2016).

WIP Drives Tumor Progression through YAP/TAZ-Dependent Autonomous Cell Growth

CELL REPORTS. Article. 17(8):1962-1977.
[doi:10.1016/j.celrep.2016.10.064]
Costa C, Santos M, Martínez-Fernández M, Lorz C, Lázaro S, Paramio JM (2016).

Deregulation of the pRb-E2F4 axis alters epidermal homeostasis and favors tumor development

Oncotarget. Article. 7(46):75712-75728.
[doi:10.18632/oncotarget.12362]
Caro M, Font A, Comas S, Viciano M, Remon J, Céliz P, Robles J, Musulén E, Sendrós MJ, Mesalles E, Jiménez JA, Boix J, Arellano A, Fernández-Llamazares J (2016).

Preoperative low-dose weekly cisplatin and continuous infusion fluorouracil plus hyperfractionated radiotherapy in stage II-III esophageal carcinoma

CLINICAL & TRANSLATIONAL ONCOLOGY. Article. 18(11):1106-1113.
[doi:10.1007/s12094-016-1488-y]
De la Rosa Kehrmann F, García González L, Pamplona Casamayor M, Rodríguez Antolín A, Duarte Ojeda J, Villacampa Aubá F, Medina Polo J, González Monte E, Serrano A, Passas Martínez J (2016).

PROGRES EN UROLOGIE. Article. 26(13):713-713.
[doi:10.1016/j.purol.2016.07.094]
Tordella L, Khan S, Hohmeyer A, Banito A, Klotz S, Raguz S, Martin N, Dhamarlingam G, Carroll T, González Meljem JM, Deswal S, Martínez-Barbera JP, García-Escudero R, Zuber J, Zender L, Gil J (2016).

SWI/SNF regulates a transcriptional program that induces senescence to prevent liver cancer

GENES & DEVELOPMENT. Article. 30(19):2187-2198.
[doi:10.1101/gad.286112.116]
Cascales Garcia, M. A., Colmenero, M., Rodriguez Antolin, A., Samper Ots, P. M., Valero, J., Gonzalez Sansegundo, C., Cabrera, J. A., Gomez Veiga, F., Couselo, M. L., Garcia Gomez, B., Hernando Arteche, A., Ponce Diaz-Reixa, J., Rubio, C., Rodriguez Cabrera, M., Martin-Arriscado, C., Lora, D., Paz-Ares, L. G., Cabeza Rodriguez, M. D. L. A. (2016).

Measuring Quality of Life in Low-Risk Prostate Cancer Treated With; Surgery, External Beam Radiation Therapy, or Brachytherapy. CAPCIRAB; Project: A Prospective, Multicentric Cohort Study

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. Meeting Abstract. 96(2):277-277.
Robles NR, Peces R, Gómez-Ferrer Á, Villacampa F, Álvarez-Ossorio JL, Pérez-Segura P, Morote J, Herrera-Imbroda B, Nieto J, Carballido J, Anido U, Valero M, Meseguer C, Torra R (2016).

Everolimus safety and efficacy for renal angiomyolipomas associated with tuberous sclerosis complex: a Spanish expanded access trial

ORPHANET JOURNAL OF RARE DISEASES. Article. 11(1):128-128.
[doi:10.1186/s13023-016-0517-9]
Chorny A, Casas-Recasens S, Sintes J, Shan M, Polentarutti N, García-Escudero R, Walland AC, Yeiser JR, Cassis L, Carrillo J, Puga I, Cunha C, Bastos H, Rodrigues F, Lacerda JF, Morais A, Dieguez-Gonzalez R, Heeger PS, Salvatori G, Carvalho A, Garcia-Sastre A, Blander JM, Mantovani A, Garlanda C, Cerutti A (2016).

The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells

JOURNAL OF EXPERIMENTAL MEDICINE. Article. 213(10):2167-2185.
[doi:10.1084/jem.20150282]
Andradas C, Blasco-Benito S, Castillo-Lluva S, Dillenburg-Pilla P, Diez-Alarcia R, Juanes-García A, García-Taboada E, Hernando-Llorente R, Soriano J, Hamann S, Wenners A, Alkatout I, Klapper W, Rocken C, Bauer M, Arnold N, Quintanilla M, Megías D, Vicente-Manzanares M, Urigüen L, Gutkind JS, Guzmán M, Pérez-Gómez E, Sánchez C (2016).

Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer.

Oncotarget. Article. 7(30):47565-47575.
[doi:10.18632/oncotarget.10206]
García-Donas J, Beuselinck B, Inglada-Pérez L, Graña O, Schöffski P, Wozniak A, Bechter O, Apellániz-Ruiz M, Leandro-García LJ, Esteban E, Castellano DE, González Del Alba A, Climent MA, Hernando S, Arranz JA, Morente M, Pisano DG, Robledo M, Rodriguez-Antona C (2016).

Deep sequencing reveals microRNAs predictive of antiangiogenic drug response

JCI insight. Article. 1(10).
[doi:10.1172/jci.insight.86051]
Gijón M, Bellusci M, Petraitiene B, Noguera-Julian A, Zilinskaite V, Sanchez Moreno P, Saavedra-Lozano J, Glikman D, Daskalaki M, Kaiser-Labusch P, Falup-Pecurariu O, Montagnani C, Prieto L, Gené A, Trumpulyte G, Kulecnikova I, Lepe JA, Cercenado E, Kudinsky R, Makri A, Huppertz HI, Bleotu L, Cocchi P, García-Hierro P, Vitkauskiene A, Fortuny C, Zukovskaja V, Neth O, Santos M, Rokney A, Petra M, Lixandru R, Galli L, Guillén S, Chaves F, Rojo Conejo P (2016).

Factors associated with severity in invasive community-acquired Staphylococcus aureus infections in children: a prospective European multicentre study

CLINICAL MICROBIOLOGY AND INFECTION. Article. 22(7).
[doi:10.1016/j.cmi.2016.04.004]
Jimenez-Ubieto, A., Garcia-Gigorro, R., Martinez-Sanchez, P., Rodriguez, A., Montejano, L., Grande, C. (2016).

ICU AND LONG-TERM MORTALITY ANALISIS OF HEMATOLOGOGICAL MALIGNANCIES ADMITTED IN ICU. A UNICENTRIC SEVEN YEARS REVIEW IN A SPANISH HOSPITAL

HAEMATOLOGICA. Meeting Abstract. 101(1):598-598.
Alameda JP, Gaspar M, Ramírez Á, Navarro M, Page A, Suárez-Cabrera C, Fernández MG, Mérida JR, Paramio JM, García-Fernández RA, Fernández-Aceñero MJ, Casanova ML (2016).

Deciphering the role of nuclear and cytoplasmic IKK beta in skin cancer

Oncotarget. Article. 7(20):29531-29547.
[doi:10.18632/oncotarget.8792]
Powles, Thomas, Lackner, Mark R., Oudard, Stephane, Escudier, Bernard, Ralph, Christy, Brown, Janet E., Hawkins, Robert E., Castellano, Daniel, Rini, Brian I., Staehler, Michael D., Ravaud, Alain, Lin, Wei, O'Keeffe, Bridget, Wang, Yulei, Lu, Shan, Spoerke, Jill M., Huw, Ling-Yuh, Byrtek, Michelle, Zhu, Rui, Ware, Joseph A., Motzer, Robert J. (2016).

Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma

JOURNAL OF CLINICAL ONCOLOGY. Article. 34(14):1660-204.
[doi:10.1200/JCO.2015.64.8808]
Rosenberg, Jonathan E., Hoffman-Censits, Jean, Powles, Tom, van der Heijden, Michiel S., Balar, Arjun V., Necchi, Andrea, Dawson, Nancy, O'Donnell, Peter H., Balmanoukian, Ani, Loriot, Yohann, Srinivas, Sandy, Retz, Margitta M., Grivas, Petros, Joseph, Richard W., Galsky, Matthew D., Fleming, Mark T., Petrylak, Daniel P., Perez-Gracia, Jose Luis, Burris, Howard A., Castellano, Daniel, Canil, Christina, Bellmunt, Joaquim, Bajorin, Dean, Nickles, Dorothee, Bourgon, Richard, Frampton, Garrett M., Cui, Na, Mariathasan, Sanjeev, Abidoye, Oyewale, Fine, Gregg D., Dreicer, Robert (2016).

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

LANCET. Article. 387(10031):1909-1920.
[doi:10.1016/S0140-6736(16)00561-4]
Gómez S, Prieto C, Vera C, R Otero J, Folgueira L (2016).

Evaluation of a new rapid diagnostic test for the detection of influenza and RSV

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. Article. 34(5):298-302.
[doi:10.1016/j.eimc.2015.05.007]
Miñana B, Rodríguez-Antolín A, Gómez-Veiga F, Hernández C, Suárez JF, Fernández-Gómez JM, Unda M, Burgos J, Alcaraz A, Rodríguez P, Moreno C, Pedrosa E, Cózar JM, Grupo Español de Cáncer de Próstata (GESCAP) (2016).

Treatment trends for clinically localised prostate cancer. National population analysis: GESCAP group

ACTAS UROLOGICAS ESPANOLAS. Article. 40(4):209-216.
[doi:10.1016/j.acuro.2015.09.005]
Camps, C, Albanell, J, Anton, A, Aranda, E, Carrato, A, Cassinello, J, Castellano, D, Cruz, JJ, Garrido, P, Guillem, V, Gravalos, C, Lopez, G, Llorente, C, Lorenzo, A, Lluch, A, Ignacio, E, Diaz-Rubio, E (2016).

Quality Indicators to Assure and Improve Cancer Care in Spain Using the Delphi Technique

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. Article. 14(5):553-558.
[doi:10.6004/jnccn.2016.0063]
Robles, Nicolas R., Peces, Ramon, Gomez-Ferrer, Alvaro, Villacampa, Felipe, Alvarez-Ossorio, Jose L., Perez, Pedro, Trilla, Enrique, Herrera, Bernardo, Nieto, Javier, Carballido, Joaquin, Anido, Urbano, Meseguer, Cristina, Torra, Roser (2016).

THE EFFECT OF EVEROLIMUS IN PATIENTS WITH RENAL ANGIOMYOLIPOMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX

NEPHROLOGY DIALYSIS TRANSPLANTATION. Meeting Abstract. 31(1):355-356.
Page, Angustias, Navarro, Manuel, Suarez-Cabrera, Cristian, Alameda, Josefa P., Casanova, M. Llanos, Paramio, Jesus M., Bravo, Ana, Ramirez, Angel (2016).

Protective role of p53 in skin cancer: Carcinogenesis studies in mice lacking epidermal p53

Oncotarget. Article. 7(15):20902-20918.
[doi:10.18632/oncotarget.7897]
Bozzini G, Provenzano M, Romero Otero J, Margreiter M, Garcia Cruz E, Osmolorskij B, Verze P, Pavan N, Sanguedolce F, Buffi N, Guazzoni G, Taverna G (2016).

Role of Penile Doppler US in the Preoperative Assessment of Penile Squamous Cell Carcinoma Patients: Results From a Large Prospective Multicenter European Study

UROLOGY. Article. 90:131-135.
[doi:10.1016/j.urology.2016.01.003]
Perez-Valderrama, B., Arranz Arija, J. A., Rodriguez Sanchez, A., Pinto Marin, A., Borrega Garcia, P., Castellano Gaunas, D. E., Rubio Romero, G., Maximiano Alonso, C., Villa Guzman, J. C., Puertas Alvarez, J. L., Chirivella Gonzalez, I., Mendez Vidal, M. J., Juan Fita, M. J., Leon-Mateos, L., Lazaro Quintela, M., Garcia Dominguez, R., Jurado Garcia, J. M., Velez de Mendizabal, E., Lambea Sorrosal, J. J., Garcia Carbonero, I., Gonzalez del Alba, A., Suarez Rodriguez, C., Jimenez Gallego, P., Meana Garcia, J. A., Garcia Marrero, R. D., Gajate Borau, P., Santander Lobera, C., Molins Palau, C., Lopez Brea, M., Fernandez Parra, E. M., Reig Torras, O., Basterretxea Badiola, L., Vazquez Estevez, S., Gonzalez Larriba, J. L. (2016).

Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study

ANNALS OF ONCOLOGY. Article. 27(4):706-711.
[doi:10.1093/annonc/mdv601]
Lalueza, Antonio, Ruiz, Sebastian, Villacampa, Felipe, Lopez, Rocio, Zabia, Elena, Sarandeses, Pilar, Cristina Hernandez, Ana, Maria Herrero, Juan, Lumbreras, Carlos (2016).

Recurrent Aortitis Associated With IgG4-Related Disease

CIRCULATION JOURNAL. Editorial Material. 80(4):1044-1044.
[doi:10.1253/circj.CJ-15-1186]
Romero-Otero, Javier, Garcia-Gomez, Borja, Duarte-Ojeda, Jose M., Rodriguez-Antolin, Alfredo, Vilaseca, Antoni, Carlsson, Sigrid V., Touijer, Karim A. (2016).

Active surveillance for prostate cancer

INTERNATIONAL JOURNAL OF UROLOGY. Review. 23(3):211-218.
[doi:10.1111/iju.13016]
Lainez, Nuria, Garcia-Donas, Jesus, Esteban, Emilio, Puente, Javier, Isabel Saez, M., Gallardo, Enrique, Pinto-Marin, Alvaro, Vazquez-Estevez, Sergio, Leon, Luis, Garcia-Carbonero, Icar, Suarez-Rodriguez, Cristina, Molins, Carmen, Climent-Duran, Miguel A., Lazaro-Quintela, Martin, Gonzalez del Alba, Aranzazu, Jose Mendez-Vidal, Maria, Chirivella, Isabel, Afonso, Francisco J., Lopez-Brea, Marta, Sala-Gonzalez, Nuria, Domenech, Montserrat, Basterretxea, Laura, Santander-Lobera, Carmen, Gil-Arnaiz, Irene, Fernandez, Ovidio, Caballero-Diaz, Cristina, Mellado, Begona, Marrupe, David, Garcia-Sanchez, Jose, Sanchez-Escribano, Ricardo, Fernandez Parra, Eva, Villa Guzman, Jose C., Martinez-Ortega, Esther, Belen Gonzalez, Maria, Moran, Marina, Suarez-Paniagua, Beatriz, Lecumberri, Maria J., Castellano, Daniel (2016).

Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study

BMC CANCER. Article. 16(1):135-135.
[doi:10.1186/s12885-016-2084-9]
Diekstra, M. H., Belaustegui, A., Swen, J. J., Boven, E., Castellano, D., Gelderblom, H., Mathijssen, R. H., Garcia-Donas, J., Rodriguez-Antona, C., Rini, B. I., Guchelaar, H. (2016).

SUNITINIB-INDUCED HYPERTENSION IN CYP3A4 RS4646437 A-ALLELE CARRIERS WITH METASTATIC RENAL CELL CARCINOMA.

CLINICAL PHARMACOLOGY & THERAPEUTICS. Meeting Abstract. 99(1):10-11.
Diekstra, M. H., Belaustegui, A., Swen, J. J., Boven, E., Castellano, D., Gelderblom, H., Mathijssen, R. H., Garcia-Donas, J., Rodriguez-Antona, C., Rini, B. I., Guchelaar, H. (2016).

SUNITINIB-INDUCED HYPERTENSION IN CYP3A4 RS4646437 A-ALLELE CARRIERS WITH METASTATIC RENAL CELL CARCINOMA.

CLINICAL PHARMACOLOGY & THERAPEUTICS. Meeting Abstract. 99(1):24-24.
Liu, X., Diekstra, M. H., Swen, J. J., Boven, E., Castellano, D., Gelderblom, H., Mathijssen, R. H., Rodriguez-Antona, C., Garcia-Donas, J., Rini, B. I., Guchelaar, H. (2016).

ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN IL8 AND IL13 WITH SUNITINIB-INDUCED TOXICITY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA.

CLINICAL PHARMACOLOGY & THERAPEUTICS. Meeting Abstract. 99(1):84-84.
Liu, X., Diekstra, M. H., Swen, J. J., Boven, E., Castellano, D., Gelderblom, H., Mathijssen, R. H., Rodriguez-Antona, C., Garcia-Donas, J., Rini, B. I., Guchelaar, H. (2016).

ASSOCIATION OF SINGLE NUCLEOTIDE POLYMORPHISMS IN IL8 AND IL13 WITH SUNITINIB-INDUCED TOXICITY IN PATIENTS WITHMETASTATIC RENAL CELL CARCINOMA.

CLINICAL PHARMACOLOGY & THERAPEUTICS. Meeting Abstract. 99(1):6-7.
Grande, Enrique, Castellano, Daniel E., Custodio, Ana B., Garcia-Carbonero, Rocio, Gonzalez, Encarnacion, Lopez-Lopez, Carlos, Munarriz, Javier, Sevilla, Isabel, Teule, Alexandre, Vinuales, Marta Benavent, Alonso, Teresa, Borau, Pablo Gajate, Palacios, Jose, Capdevila, Jaume (2016).

A phase II trial to assess the activity and safety of the hypoxia-activated prodrug evofosfamide (TH-302) in combination with sunitinib in patients with disseminated grade 1 and 2 pancreatic neuroendocrine tumors (pNET) as a first-line approach: The GETNE-1408 trial.

JOURNAL OF CLINICAL ONCOLOGY. Meeting Abstract. 34(4, S).
[doi:10.1200/jco.2016.34.4_suppl.tps479]
Raymond, Eric, Niccoli, Patricia, Castellano, Daniel, Valle, Juan W., Hammel, Pascal, Raoul, Jean-Luc, Vinik, Aaron, Bang, Yung-Jue, Lee, Se-Hoon, Borbath, Ivan, Bohas, Catherine Lombard, Metrakos, Peter, Smith, Denis Michel, Chen, Jen-Shi, Seitz, Jean Francois, Patyna, Shem, Huang, Xin, Ishak, Jack, Faivre, Sandrine J., Ruszniewski, Philippe B. (2016).

Sunitinib (SU) in patients with advanced, progressive pancreatic neuroendocrine tumors (pNET): Final overall survival (OS) results from a phase III randomized study including adjustment for crossover

JOURNAL OF CLINICAL ONCOLOGY. Meeting Abstract. 34(4, S).
[doi:10.1200/jco.2016.34.4_suppl.309]
Martínez-Fernández M, Paramio JM, Dueñas M (2016).

RNA Detection in Urine From RNA Extraction to Good Normalizer Molecules

JOURNAL OF MOLECULAR DIAGNOSTICS. Article. 18(1):15-22.
[doi:10.1016/j.jmoldx.2015.07.008]
Manneh R, Castellano D, Caso O, Loinaz C, Jiménez J, Estenoz J, Calatayud M, Sepúlveda JM, García-Carbonero R (2016).

Well-Differentiated Grade 2, Type 3 Gastrointestinal Neuroendocrine Tumour with Bilateral Metastatic Ovarian Involvement: Report of an Unusual Case

Case reports in oncology. Article. 9(1):255-261.
[doi:10.1159/000445940]
Jimenez-Fonseca, P., Capdevila, J., Alonso Orduna, V, Fernandez Medina, I, Teule Vega, A., Marazuela Azpiroz, M., Beguiristain Gomez, A., Llanos Munoz, M., Martinez del Prado, M., Sevilla Garcia, M., Carmona-Bayonas, A., Castellano, D., Diaz Perez, J., Castano, A., Garcia Carbonero, R. (2016).

Epidemiology, Pathological Features and Clinical Outcome of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs): Results from the National Neuroendocrine Cancer Registry of Spain (R-GETNE)

NEUROENDOCRINOLOGY. Meeting Abstract. 103(1):17-17.
Raymond, E., Niccoli, P., Castellano, D., Valle, J., Hammel, P., Raoul, J. L., Vinik, A., Bang, Y. J., Lee, S. H., Borbath, I, Lombard-Bohas, C., Metrakos, P., Smith, D. M., Chen, J., Seitz, J. S., Patyna, S., Lu, D. R., Ishak, J., Faivre, S., Ruszniewski, P. (2016).

Sunitinib (SU) in Patients with Advanced, Progressive Pancreatic Neuroendocrine Tumors (pNET): Final Overall Survival (OS) Results from a Phase III Randomized Study Including Adjustment for Crossover

NEUROENDOCRINOLOGY. Meeting Abstract. 103(1):84-84.

2015

Martinez-Fernandez, Monica, Duenas, Marta, Feber, Andrew, Segovia, Cristina, Garcia-Escudero, Ramon, Rubio, Carolina, Lopez-Calderon, Fernando F., Diaz-Garcia, Claudio, Villacampa, Felipe, Duarte, Jose, Gomez-Rodriguez, Maria J., Castellano, Daniel, Rodriguez-Peralto, Jose L., de la Rosa, Federico, Beck, Stephan, Paramio, Jesus M. (2015).

A Polycomb-mir200 loop regulates clinical outcome in bladder cancer

Oncotarget. Article. 6(39):42258-42275.
[doi:10.18632/oncotarget.5546]
Motzer, Robert J., Escudier, Bernard, Mcdermott, David F., George, Saby, Hammers, Hans J., Srinivas, Sandhya, Tykodi, Scott S., Sosman, Jeffrey A., Procopio, Giuseppe, Plimack, Elizabeth R., Castellano, Daniel, Gurney, Howard, Donskov, Frede, Bono, Petri, Wagstaff, John, Gauler, Thomas C., Ueda, Takeshi, Xu, Li-An, Waxman, Ian M., Sharma, Padmanee, Checkmate 025 Invest (2015).

CheckMate 025: a randomized, open-label, phase Ill study of nivolumab versus everolimus in advanced renal cell carcinoma (RCC)

BJU INTERNATIONAL. Meeting Abstract. 116(5, SI):17-17.
Bozzini, G., Albersen, M., Romero Otero, J., Margreiter, M., Garcia Cruz, E., Mueller, A., Gratzke, C., Serefoglu, E. C., Martinez Salamanca, J. I., Verze, P. (2015).

Feasibility and safety of conservative surgery for the treatment of spermatic cord leiomyosarcoma

INTERNATIONAL JOURNAL OF SURGERY. Article. 24(A):81-84.
[doi:10.1016/j.ijsu.2015.11.012]
Diekstra MH, Liu X, Swen JJ, Boven E, Castellano D, Gelderblom H, Mathijssen RH, Rodríguez-Antona C, García-Donas J, Rini BI, Guchelaar HJ (2015).

Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. Article. 71(12):1477-1484.
[doi:10.1007/s00228-015-1935-7]
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., Castellano, D., Choueiri, T. K., Gurney, H., Donskov, F., Bono, P., Wagstaff, J., Gauler, T. C., Ueda, T., Tomita, Y., Schutz, F. A., Kollmannsberger, C., Larkin, J., Ravaud, A., Simon, J. S., Xu, L-A, Waxman, I. M., Sharma, P., CheckMate 025 Investigators (2015).

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

NEW ENGLAND JOURNAL OF MEDICINE. Article. 373(19):1803-1813.
[doi:10.1056/NEJMoa1510665]
Herranz Amo F, Hernández Fernández C, Cózar Olmo JM, Miñana López B, Gómez-Veiga F, Rodríguez-Antolín A, Pedrosa E, Grupo Español de Cáncer de Próstata (GESCAP) (2015).

Adherence to the lymphadenectomy recommendations of the 2009 clinical guidelines in the 2010 National Prostate Cancer Registry

ACTAS UROLOGICAS ESPANOLAS. Article. 39(9):546-552.
[doi:10.1016/j.acuro.2015.05.004]
Martínez-Fernández M, Rubio C, Segovia C, López-Calderón FF, Dueñas M, Paramio JM (2015).

EZH2 in Bladder Cancer, a Promising Therapeutic Target

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Review. 16(11):27107-27132.
[doi:10.3390/ijms161126000]
De La Rosa Kehrmann F, García González L, González Monte E, Rodríguez Antolín A, Pamplona Casamayor M, Duarte Ojeda J, Tejido Sánchez Á, Villacampa Aubá F, Passas Martínez J (2015).

[Not Available].

PROGRES EN UROLOGIE. Article. 25(13):722-722.
[doi:10.1016/j.purol.2015.08.013]
Martinez-Fernandez, Monica, Feber, Andrew, Duenas, Marta, Segovia, Cristina, Rubio, Carolina, Fernandez, Maria, Villacampa, Felipe, Duarte, Jose, Lopez-Calderon, Fernando F., Jose Gomez-Rodriguez, Ma, Castellano, Daniel, Rodriguez-Peralto, Jose L., de la Rosa, Federico, Beck, Stephan, Paramio, Jesus M. (2015).

Analysis of the Polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer

Clinical epigenetics. Article. 7:109-109.
[doi:10.1186/s13148-015-0141-x]
Diekstra MH, Swen JJ, Boven E, Castellano D, Gelderblom H, Mathijssen RH, Rodríguez-Antona C, García-Donas J, Rini BI, Guchelaar HJ (2015).

CYP3A5 and ABCB1 Polymorphisms as Predictors for Sunitinib Outcome in Metastatic Renal Cell Carcinoma

EUROPEAN UROLOGY. Article. 68(4):621-629.
[doi:10.1016/j.eururo.2015.04.018]
Garcia Sanz, R., Sureda, A., Gonzalez, A. P., Salar, A., Rodriguez, A., De La Cruz, F., Domiingo-Domenech, E., Canales, M., Lopez, J., Moreno, M., Rodriguez, G., Jose Luis, P., Rodriguez, M. J., Lopez-Guillermo, A., Caballero, M. D., Jimenez, S., Martinez, C. (2015).

EVALUATION OF THE BRENUTXIMAB VEDOTIN REGIME AND ESHAP (BRESHAP) IN LYMPHOMA PRIMARY RESISTANT HODGKIN'S OR IN FIRST RELAPSE: RESULTS PRELIMINARY A TRIAL PHASE I-II OF THE SPANISH GROUP OF LYMPHOMAS AND TRANSPLANTATION OF BONE MARROW (GELTAMO)

HAEMATOLOGICA. Meeting Abstract. 100(4):9-9.
Miranda-Utrera N, Medina-Polo J, Pamplona-Casamayor M, Passas-Martínez JB, Rodríguez-Antolín A, de la Rosa Kehrmann F, Duarte-Ojeda JM, Tejido-Sánchez A, Villacampa Aubá F, Andrés Belmonte A (2015).

Uncontrolled non-heartbeating donors (types I-II) with normothermic recirculation vs. heartbeating donors: Evaluation of functional results and survival

ACTAS UROLOGICAS ESPANOLAS. Article. 39(7):429-434.
[doi:10.1016/j.acuro.2015.01.005]
Grande, E., Capdevila, J., Castellano, D., Teule, A., Duran, I., Fuster, J., Sevilla, I., Escudero, P., Sastre, J., Garcia-Donas, J., Casanovas, O., Earl, J., Ortega, L., Apellaniz-Ruiz, M., Rodriguez-Antona, C., Alonso-Gordoa, T., Diez, J. J., Carrato, A., Garcia-Carbonero, R. (2015).

Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)(aEuro)

ANNALS OF ONCOLOGY. Article. 26(9):1987-1993.
[doi:10.1093/annonc/mdv252]
Capdevila, Jaume, Sevilla, Isabel, Alonso, Vicente, Anton Aparicio, Luis, Jimenez Fonseca, Paula, Grande, Enrique, Jose Reina, Juan, Luis Manzano, Jose, Alonso Lajara, Juan Domingo, Barriuso, Jorge, Castellano, Daniel, Medina, Javier, Lopez, Carlos, Segura, Angel, Carrera, Sergio, Crespo, Guillermo, Fuster, Jose, Munarriz, Javier, Garcia Alfonso, Pilar (2015).

Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis

BMC CANCER. Article. 15:495-495.
[doi:10.1186/s12885-015-1512-6]
Jimenez-Alcaide, Estibaliz, Medina-Polo, Jose, Garcia-Gonzalez, Lucia, Arrebola-Pajares, Ana, Guerrero-Ramos, Felix, Perez-Cadavid, Santiago, Sopena-Sutil, Raquel, Benitez-Sala, Rauf, Alonso-Isa, Manuel, Lara-Isla, Alba, Bautista Passas-Martinez, Juan, Tejido-Sanchez, Angel (2015).

Healthcare-associated urinary tract infections in patients with a urinary catheter: Risk factors, microbiological characteristics and patterns of antibiotic resistance.

ARCHIVOS ESPANOLES DE UROLOGIA. Article. 68(6):541-550.
Gore, M. E., Szczylik, C., Porta, C., Bracarda, S., Bjarnason, G. A., Oudard, S., Lee, S-H, Haanen, J., Castellano, D., Vrdoljak, E., Schoeffski, P., Mainwaring, P., Hawkins, R. E., Crino, L., Kim, T. M., Carteni, G., Eberhardt, W. E. E., Zhang, K., Fly, K., Matczak, E., Lechuga, M. J., Hariharan, S., Bukowski, R. (2015).

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

BRITISH JOURNAL OF CANCER. Article. 113(1):12-19.
[doi:10.1038/bjc.2015.196]
Perez-Gomez, Eduardo, Andradas, Clara, Blasco-Benito, Sandra, Caffarel, Maria M., Garcia-Taboada, Elena, Villa-Morales, Maria, Moreno, Estefania, Hamann, Sigrid, Martin-Villar, Ester, Flores, Juana M., Wenners, Antonia, Alkatout, Ibrahim, Klapper, Wolfram, Roecken, Christoph, Bronsert, Peter, Stickeler, Elmar, Staebler, Annette, Bauer, Maret, Arnold, Norbert, Soriano, Joaquim, Perez-Martinez, Manuel, Megias, Diego, Moreno-Bueno, Gema, Ortega-Gutierrez, Silvia, Artola, Marta, Vazquez-Villa, Henar, Quintanilla, Miguel, Fernandez-Piqueras, Jose, Canela, Enric I., McCormick, Peter J., Guzman, Manuel, Sanchez, Cristina (2015).

Role of Cannabinoid Receptor CB2 in HER2 Pro-oncogenic Signaling in Breast Cancer

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. Article. 107(6).
[doi:10.1093/jnci/djv077]
Romero-Otero J, Medina-Polo J, García-Gómez B, Lora-Pablos D, Duarte-Ojeda JM, García-González L, García-Cruz E, Rodríguez-Antolín A (2015).

Semen Quality Assessment in Fertile Men in Madrid During the Last 3 Decades

UROLOGY. Article. 85(6):1333-1338.
[doi:10.1016/j.urology.2015.02.001]
Kalathur M, Toso A, Chen J, Revandkar A, Danzer-Baltzer C, Guccini I, Alajati A, Sarti M, Pinton S, Brambilla L, Di Mitri D, Carbone G, Garcia-Escudero R, Padova A, Magnoni L, Tarditi A, Maccari L, Malusa F, Kalathur RK, A Pinna L, Cozza G, Ruzzene M, Delaleu N, Catapano CV, Frew IJ, Alimonti A (2015).

A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours

NATURE COMMUNICATIONS. Article. 6:7227-7227.
[doi:10.1038/ncomms8227]
Sepulveda-Sanchez, Juan, Ramos, Ana, Hilario, Amaya, De Velascoi, Guillermo, Castellano, Daniel, Garcia De La Torre, Marta, Rodon, Jordi, Lahn, Michael F. (2015).

Brain perfusion and permeability in patients with advanced, refractory glioblastoma treated with lomustine and the transforming growth factor-beta receptor I kinase inhibitor LY2157299 monohydrate

ONCOLOGY LETTERS. Article. 9(6):2442-2448.
[doi:10.3892/ol.2015.3106]
Zur, Rafal, Garcia-Ibanez, Laura, Nunez-Buiza, Angel, Aparicio, Noelia, Liappas, Georgios, Escos, Alejandra, Risco, Ana, Page, Angustias, Saiz-Ladera, Cristina, Alsina-Beauchamp, Dayanira, Montans, Jose, Paramio, Jesus M., Cuenda, Ana (2015).

Combined deletion of p38 gamma and p38 delta reduces skin inflammation and protects from carcinogenesis

Oncotarget. Article. 6(15):12920-12935.
[doi:10.18632/oncotarget.4320]
Palla, Adelaida R., Piazzolla, Daniela, Alcazar, Noelia, Canamero, Marta, Grana, Osvaldo, Gomez-Lopez, Gonzalo, Dominguez, Orlando, Duenas, Marta, Paramio, Jesus M., Serrano, Manuel (2015).

The pluripotency factor NANOG promotes the formation of squamous cell carcinomas

SCIENTIFIC REPORTS. Article. 5:10205-10205.
[doi:10.1038/srep10205]
Marin-Ramos, Nagore I., Alonso, Dulce, Ortega-Gutierrez, Silvia, Ortega-Nogales, Francisco J., Balabasquer, Moises, Vazquez-Villa, Henay, Andradas, Clara, Blasco-Benito, Sandra, Perez-Gomez, Eduardo, Canales, Angeles, Jimenez-Barbero, Jesus, Marquina, Ana, Moscoso del Prado, Jaime, Sanchez, Cristina, Martin-Fontecha, Mar, Lopez-Rodriguez, Maria L. (2015).

New Inhibitors of Angiogenesis with Antitumor Activity in Vivo

JOURNAL OF MEDICINAL CHEMISTRY. Article. 58(9):3757-3766.
[doi:10.1021/jm5019252]
Garcia Gomez, B., Romero Otero, J., Medina Polo, J., Garcia Gonzalez, L., Jimenez Alcaide, F., Rodriguez Antolin, A., Passas Martinez, J. (2015).

CRITICAL EVALUATION OF PEYRONIE'S DISEASE (PD) TREATMENT WITH PLAQUE EXCISION AND GRAFTING OF THE TUNICAL DEFECT WITH LYOPHILIZED BOVINE PERICARDIUM

The journal of sexual medicine. Meeting Abstract. 12(3, SI):247-247.
Medina-Polo, J., Javier, R. -O, Garcia-Gomez, B., David, L. -P, Jimenez-Alcaide, E., Garcia-Gonzalez, L., Arrebola-Pajares, A., Rodriguez-Antolin, A., Garcia Cruz, E. (2015).

SEMEN QUALITY ASSESSMENT IN FERTILE MEN IN SPAIN DURING THE LAST THREE DECADES

The journal of sexual medicine. Meeting Abstract. 12(3, SI):253-254.
Garcia Gonzalez, L., Romero Otero, J., Sopena Sutil, R., Jimenez Alcaide, E., Garcia Gomez, B., Duarte Ojeda, J. M., Rodriguez Antolin, A., Romero Otero, J. (2015).

PROSPECTIVE EVALUATION OF THE EARLY IMPACT OF THE LHRH ANALOGUES IN THE TREATMENT OF PROSTATE CANCER IN SEXUAL, PSYCHO-COGNITIVE, EMOTIONAL AND QUALITY OF LIFE PARAMETERS

The journal of sexual medicine. Meeting Abstract. 12(3, SI):238-238.
Garcia Cruz, E., Martinez-Salamanca, I, J., Javier, R. (2015).

ERECTILE DYSFUNCTION AND AGING SYMPTOMS ARE RELATED TO A HIGHER CHARLSON COMORBIDITY INDEX

The journal of sexual medicine. Meeting Abstract. 12(3, SI):235-236.
Garcia Cruz, E., Martinez-Salamanca, J., Romero Otero, J. (2015).

ERECTILE DYSFUNCTION CORRELATES WITH METS IN MEN WITH MODERATE PROSTATIC SYMPTOMS

The journal of sexual medicine. Meeting Abstract. 12(3, SI):235-235.
Alajati, Abdullah, Guccini, Ilaria, Pinton, Sandra, Garcia-Escudero, Ramon, Bernasocchi, Tiziano, Sarti, Manuela, Montani, Erica, Rinaldi, Andrea, Montemurro, Filippo, Catapano, Carlo, Bertoni, Francesco, Alimonti, Andrea (2015).

Interaction of CDCP1 with HER2 Enhances HER2-Driven Tumorigenesis and Promotes Trastuzumab Resistance in Breast Cancer

CELL REPORTS. Article. 11(4):564-576.
[doi:10.1016/j.celrep.2015.03.044]
Tome-Amat, Jaime, Olombrada, Miriam, Ruiz-de-la-Herran, Javier, Perez-Gomez, Eduardo, Andradas, Clara, Sanchez, Cristina, Martinez, Leopoldo, Martinez-del-Pozo, Alvaro, Gavilanes, Jose G., Lacadena, Javier (2015).

Efficient in vivo antitumor effect of an immunotoxin based on ribotoxin alpha-sarcin in nude mice bearing human colorectal cancer xenografts

Springerplus. Article. 4:168-168.
[doi:10.1186/s40064-015-0943-5]
de Velasco, Guillermo, Munoz, Cesar, Sepulveda, Juan M., Castellano, Daniel (2015).

Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): Case report and review of the literature

CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL. Article. 9(3-4):243-246.
[doi:10.5489/cuaj.2264]
Contreras-Jurado C, Lorz C, García-Serrano L, Paramio JM, Aranda A (2015).

Thyroid hormone signaling controls hair follicle stem cell function

MOLECULAR BIOLOGY OF THE CELL. Article. 26(7):1263-1272.
[doi:10.1091/mbc.E14-07-1251]
Guillem, Vicente, Angel Climent, Miguel, Cassinello, Javier, Esteban, Emilio, Castellano, Daniel, Luis Gonzalez-Larriba, Jose, Maroto, Pablo, Camps, Carlos (2015).

Controversies in the treatment of invasive urothelial carcinoma: a case report and review of the literature

BMC UROLOGY. Article. 15(1):15-15.
[doi:10.1186/s12894-015-0008-7]
Morales P, Blasco-Benito S, Andradas C, Gómez-Cañas M, Flores JM, Goya P, Fernández-Ruiz J, Sánchez C, Jagerovic N (2015).

Selective, Nontoxic CB2 Cannabinoid o-Quinone with in Vivo Activity against Triple-Negative Breast Cancer

JOURNAL OF MEDICINAL CHEMISTRY. Article. 58(5):2256-2264.
[doi:10.1021/acs.jmedchem.5b00078]
Fernandez Calvo, Ovidio, Fernandez Parra, Eva, Perez-Valderrama, Begona, Mellado, Begona, Ochoa de Olza, Maria, Castellano, Daniel E., Domenech, Montserrat, Hernando Polo, Susana, Anido, Urbano, Arranz Arija, Jose Angel, Caballero, Cristina, Jose Juan, M., Duran, Ignacio, Campayo, Marc, Serrano, Monica, Angel Climent, Miguel (2015).

Weekly cabazitaxel in ``unfit'' metastatic castration-resistant prostate cancer patients (mCRPC) progressing after docetaxel (D) treatment: Preliminary results of CABASEM-SOGUG phase II trial.

JOURNAL OF CLINICAL ONCOLOGY. Meeting Abstract. 33(7, S).
Maraver, Antonio, Fernandez-Marcos, Pablo J., Cash, Timothy P., Mendez-Pertuz, Marinela, Duenas, Marta, Maietta, Paolo, Martinelli, Paola, Munoz-Martin, Maribel, Martinez-Fernandez, Monica, Canamero, Marta, Roncador, Giovanna, Martinez-Torrecuadrada, Jorge L., Grivas, Dimitrios, Luis de la Pompa, Jose, Valencia, Alfonso, Paramio, Jesus M., Real, Francisco X., Serrano, Manuel (2015).

NOTCH pathway inactivation promotes bladder cancer progression

JOURNAL OF CLINICAL INVESTIGATION. Article. 125(2):824-830.
[doi:10.1172/JCI78185]
Diekstra, M., Swen, J. J., Boven, E., Castellano, D., Ganapathi, R., Gelderblom, H., Mathijssen, R. H., Rodriguez-Antona, C., Garcia-Donas, J., Rini, B., Guchelaar, H. (2015).

A MULTICENTER VALIDATION STUDY OF GENETIC POLYMORPHISMS ASSOCIATED WITH TOXICITY AND EFFICACY OF SUNITINIB IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA.

CLINICAL PHARMACOLOGY & THERAPEUTICS. Meeting Abstract. 97(1):13-13.
Velasco G, Sánchez C, Guzmán M (2015).

Endocannabinoids and Cancer.

Handbook of experimental pharmacology. Article. 231:449-472.
[doi:10.1007/978-3-319-20825-1_16]

Alameda, JP, Navarro M, Ramírez Á, Page A, Suárez-Cabrera C, Moreno-Maldonado R, Paramio JM, Fariña MD, Del Río M, Fernández-Aceñero MJ, Bravo A, Casanova ML ().

IKKa regulates the stratification and differentiation of the epidermis: implications for skin cancer development.

Oncotarget. Article.